509 related articles for article (PubMed ID: 23196570)
41. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
A Armstrong R
Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
[TBL] [Abstract][Full Text] [Related]
42. Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions.
Hart MP; Brettschneider J; Lee VM; Trojanowski JQ; Gitler AD
Acta Neuropathol; 2012 Aug; 124(2):221-30. PubMed ID: 22526021
[TBL] [Abstract][Full Text] [Related]
43. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue.
Liu-Yesucevitz L; Bilgutay A; Zhang YJ; Vanderweyde T; Citro A; Mehta T; Zaarur N; McKee A; Bowser R; Sherman M; Petrucelli L; Wolozin B
PLoS One; 2010 Oct; 5(10):e13250. PubMed ID: 20948999
[TBL] [Abstract][Full Text] [Related]
44. Atypical FTLD-FUS associated with ALS-TDP: a case report.
Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
[TBL] [Abstract][Full Text] [Related]
45. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
Lourenco GF; Janitz M; Huang Y; Halliday GM
Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
[TBL] [Abstract][Full Text] [Related]
46. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
Ito D; Seki M; Tsunoda Y; Uchiyama H; Suzuki N
Ann Neurol; 2011 Jan; 69(1):152-62. PubMed ID: 21280085
[TBL] [Abstract][Full Text] [Related]
47. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span.
Wang JW; Brent JR; Tomlinson A; Shneider NA; McCabe BD
J Clin Invest; 2011 Oct; 121(10):4118-26. PubMed ID: 21881207
[TBL] [Abstract][Full Text] [Related]
48. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations.
Finelli MJ; Liu KX; Wu Y; Oliver PL; Davies KE
Hum Mol Genet; 2015 Jun; 24(12):3529-44. PubMed ID: 25792726
[TBL] [Abstract][Full Text] [Related]
49. TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis.
Toyoshima Y; Takahashi H
Neuropathology; 2014 Feb; 34(1):77-82. PubMed ID: 23889603
[TBL] [Abstract][Full Text] [Related]
50. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA.
Kim SH; Shanware NP; Bowler MJ; Tibbetts RS
J Biol Chem; 2010 Oct; 285(44):34097-105. PubMed ID: 20720006
[TBL] [Abstract][Full Text] [Related]
51. Misregulated RNA processing in amyotrophic lateral sclerosis.
Polymenidou M; Lagier-Tourenne C; Hutt KR; Bennett CF; Cleveland DW; Yeo GW
Brain Res; 2012 Jun; 1462():3-15. PubMed ID: 22444279
[TBL] [Abstract][Full Text] [Related]
52. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
[TBL] [Abstract][Full Text] [Related]
53. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43.
Lanson NA; Maltare A; King H; Smith R; Kim JH; Taylor JP; Lloyd TE; Pandey UB
Hum Mol Genet; 2011 Jul; 20(13):2510-23. PubMed ID: 21487023
[TBL] [Abstract][Full Text] [Related]
54. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.
Daigle JG; Krishnamurthy K; Ramesh N; Casci I; Monaghan J; McAvoy K; Godfrey EW; Daniel DC; Johnson EM; Monahan Z; Shewmaker F; Pasinelli P; Pandey UB
Acta Neuropathol; 2016 Apr; 131(4):605-20. PubMed ID: 26728149
[TBL] [Abstract][Full Text] [Related]
55. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
[No Abstract] [Full Text] [Related]
56. NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility.
Gleixner AM; Verdone BM; Otte CG; Anderson EN; Ramesh N; Shapiro OR; Gale JR; Mauna JC; Mann JR; Copley KE; Daley EL; Ortega JA; Cicardi ME; Kiskinis E; Kofler J; Pandey UB; Trotti D; Donnelly CJ
Nat Commun; 2022 Jun; 13(1):3380. PubMed ID: 35697676
[TBL] [Abstract][Full Text] [Related]
57. Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS.
Motaln H; Čerček U; Yamoah A; Tripathi P; Aronica E; Goswami A; Rogelj B
Brain; 2023 Oct; 146(10):4088-4104. PubMed ID: 37071594
[TBL] [Abstract][Full Text] [Related]
58. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD.
Tamaki Y; Urushitani M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293362
[TBL] [Abstract][Full Text] [Related]
59. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
60. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]